A Bold Panoramic Grasp of Tardive Dyskinesia

This presentation on tardive dyskinesia reviews the prevalence of TD in patients with anxiety and mood disorders, the evidence base for utilizing patient insight into the diagnosis of TD, and current treatments for TD.
Christoph U. Correll, MD
Format: Adobe Acrobat (.pdf)
File Size: 534 KB
Released: March 23, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Neurocrine Biosciences, Inc.
Teva Pharmaceuticals

Related Content

Downloadable slides from the major depressive disorder presentation at the 2022 Psychopharmacology Update conference (CCO)

Greg W. Mattingly, MD Released: December 1, 2022

Downloadable slides from the antidepressants presentation at the 8th Annual Psychopharmacology Update 2022 (CCO)

Anita Clayton, MD Released: December 1, 2022

Downloadable slides from the ADHD presentation at the 8th Annual Psychopharmacology Update 2022 (CCO)

Vladimir Maletic, MD Released: November 30, 2022

Downloadable slides from the LAI antipsychotics presentation at the 2022 Psychopharmacology Update conference, from Clinical Care Options (CCO)

Leslie Citrome, MD, MPH Released: November 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings